Dr. Reinerio Deza | Head Global Pharmacovigilance
Cubist Pharmaceuticals, Inc.

Dr. Reinerio A. Deza, currently Head of Pharmacovigilance at Cubist Pharmaceuticals, has over 20 years of experience in the pharmaceutical industry, primarily in Pharmacovigilance (PV) but has also included Medical Affairs. Most recently, Rene was at Merck (Schering-Plough) as the Sr. Director of Medical Services and the Clinical Risk Management Group. Dr. Deza’s prior work experience has also included tenures at GlaxoSmithKline Consumer HealthCare (Director of Medical Affairs and Drug Safety for North America), Bristol-Myers Squibb (Squibb Diagnostics), Bracco Diagnostics, and Gilead Sciences with the latter two companies as Head of the Global Drug Safety departments. Prior to joining the industry, Dr. Deza was a research scientist, in the Epidemiology Department with the CDC and the Division of AIDS, NJ Dept. of Health, and was Department Head of Microbiology & Parasitology in the College of Medicine at WVSU, Philipppines. Dr. Deza has an MD from the University Of Santo Tomas Philippines with training and clinical practice in Occupational and Industrial Medicine.